Viewing Study NCT01951235


Ignite Creation Date: 2025-12-24 @ 10:06 PM
Ignite Modification Date: 2026-01-29 @ 4:25 PM
Study NCT ID: NCT01951235
Status: COMPLETED
Last Update Posted: 2015-08-13
First Post: 2013-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes
Sponsor: Poxel SA
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-01
Start Date Type: None
Primary Completion Date: 2014-07
Primary Completion Date Type: ACTUAL
Completion Date: 2014-07
Completion Date Type: ACTUAL
First Submit Date: 2013-09-19
First Submit QC Date: None
Study First Post Date: 2013-09-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2015-08-13
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2015-07-24
Last Update Post Date: 2015-08-13
Last Update Post Date Type: ESTIMATED